(Q39827544)

15 September 2017

title

Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog. (English)

1 reference

15 September 2017

Lien EL

1 reference

15 September 2017

Fenichel RL

1 reference

15 September 2017

Grant NH

1 reference

15 September 2017

Boxill GC

1 reference

15 September 2017

Greenwood J

1 reference

15 September 2017

Yardley JP

1 reference

15 September 2017

publication date

1 August 1977

1 reference

Biochemical and Biophysical Research Communications

15 September 2017

published in

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

1317-1325

1 reference

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Inhibition of growth hormone secretion in the rat by synthetic somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

The Response of Pancreatic and Pituitary Hormones to Pulses and Constant Infusion of Somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

A novel cyclic undercapeptide, WY-40, 770, with prolonged growth hormone release inhibiting activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Removal of protected peptides by hydrazinolysis after solid-phase synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Studies of GH Secretion in Mice by a Homologous Radioimmunoassay for Mouse GH1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Immunoassay of insulin with insulin-antibody precipitate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

D-Trp8-somatostatin: An analog of somatostatin more potent than the native molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Correlation between biological potency and biodegradation of a somatostatin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Abnormal serum growth hormone response to exercise in juvenile diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

Growth hormone and diabetes in man. Old concepts--new implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2877%2980123-X

10.1016/S0006-291X(77)80123-X

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference